Mark Sheptoff Financial Planning’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$604 Hold
400
﹤0.01% 493
2025
Q1
$1.2K Sell
400
-500
-56% -$1.5K ﹤0.01% 417
2024
Q4
$9.07K Sell
900
-400
-31% -$4.03K ﹤0.01% 325
2024
Q3
$20.1K Buy
+1,300
New +$20.1K 0.01% 246